Blood & Marrow Transplant Program

The Blood and Marrow Transplant Program at Northside Hospital provides the best of both worlds – clinical excellence and compassionate care. NSH-BMT is one of the largest clinical transplant programs in the Southeastern United States and serves patients undergoing bone marrow/stem cell transplant therapy and provides primary leukemia management.

To refer a patient or speak to a NSH-BMT physician, please call (404)255-1930. NSH-BMT physicians are on call 24 hours a day, seven days a week. 

For the fifth consecutive year, NSH-BMT’s commitment to quality patient care has resulted in the following:

  • Nationally, NSH-BMT achieved survival outcomes that significantly exceeded the expected range in related and  unrelated donor transplant.
  • NSH-BMT was one of ten adult centers in the country to achieve this statistically significant outcome.
  • NSH-BMT is the ONLY program in Georgia to have one-year survival outcomes that exceeded expected outcomes.
  • NSH-BMT is one of only two programs in the country who have exceeded expected outcomes for the last 5 reporting cycles.
  • The NMDP/CIBMTR has 169 adult and pediatric transplant centers in its network.
  • This analysis includes ONLY patients who received their first allogeneic transplant between January 1, 2009 and December 31, 2011  using unrelated or related donors, and who had reported follow-up.
  • Center-Specific Analysis is adjusted for the mix of risk factors that can affect patient survival, such as HLA Matching, recipient's age, disease and stage, and overall health before transplant.
  • For more information, please visit www.bethematch.org

1. Reported outcome data from www.bethematch.com. This survival information includes only patients who received their first allogeneic transplant between January 1, 2009 and December 31, 2011 using unrelated or related donors, and who had reported follow-up.

2. Final 2013 Transplant Center Specific Survival Report, December 27, 2013.  

 

Clinical Research

Clinical research is a major component of the NSH-BMT Program. The high quality of our research program has been recognized by the National Institutes of Health (NIH) as demonstrated by our designation as a primary core clinical center for the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN). NSH-BMT joins only 19 other elite BMT Programs (and is the only one in the state of Georgia) in becoming a primary recipient of this competitive award and status.

The Leukemia and Lymphoma Society (LLS) and the Dana-Farber Cancer Institute have also established a network of sites for clinical trial testing of innovative blood cancer therapies in community oncology settings across the country. This groundbreaking Blood Cancer Research Partnership (BCRP), dana-farber.org/BCRP, will bring clinical trials closer to where patients live and help to address one of the primary bottlenecks in the development of new cancer therapies: the need for more patients to take part in clinical trials. NSH-BMT is one of ten sites who have been selected to participate in this prestigious partnership.

At NSH-BMT, your physicians and clinical research team will offer you possible treatment options including both standard of care treatment and potential clinical trials, providing you with the information you need to make an informed decision.

Important Facts to Know About Clinical Research

  • The goal of clinical research trials is to determine the safety and efficacy of new drugs which will hopefully improve survival and quality of life.
  • Participation in a clinical trial may offer you access to a new therapy for your disease which is not otherwise available, or the use of an established treatment in a new setting.
  • Your participation in clinical trials is completely voluntary.
  • When new clinical trial information is available, you will be informed by your BMT physician. 

Our experienced research team includes research nurses, pharmacists experienced in the handling of investigational agents, and laboratory personnel.

Click here to download the current listing of BMT clinical trials.

Types of Transplants Performed 

NSH-BMT serves patients undergoing bone marrow/stem cell transplant therapy and provides primary leukemia management including:

  • Autologous stem cell transplants
  • Related and unrelated allogeneic stem cell transplants
  • Haploidentical stem cell transplants
  • Cord Blood transplant 

Diseases Treated

Diseases treatable with bone marrow transplantation include:

  • Acute Myelogeneous Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Amyloidosis
  • Anaplastic Lymphoblastic Lymphoma
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia (CML)
  • Hereditary Hemoglobinopathies (Thalassemia, Sickle Cell)
  • Hodgkin’s Disease
  • Myelodysplastic Syndrome
  • Multiple Myeloma
  • Non-Hodgkin’s Lymphoma (NHL)
  • Solid Tumors amenable to transplant therapy
  • Waldenstroms Macroglobulinemia

NSH-BMT’s Comprehensive Inpatient and Outpatient Autologous and Allogeneic Transplant Program

NSH-BMT is committed to providing patients and their caregivers a comprehensive pathway to successful outcomes. Though NSH-BMT has pioneered successful outpatient transplants, we are able to provide patients with the option to also have an inpatient autologous or allogeneic transplants as well.

At the New Patient Consult and Pre-BMT Evaluation, the NSH-BMT team will meet with each patient and family member(s) to determine if an inpatient or outpatient transplant would be the best treatment/location option. We realize that for some patients, receiving an outpatient transplant is not feasible due to the lack of adequate care giver support, transportation, local housing requirements or financial considerations. The NSH-BMT team works with each patient and their unique personal situation to determine the best location to have their transplant.

Nationally, NSH-BMT has been a leader in the field of hematopoietic stem cell transplant by perfecting autologous and allogeneic transplants in the outpatient setting. BMTGA physician, Dr. Scott Solomon, wrote a peer reviewed article, Outpatient Myeloablative  Allo-SCT:  A comprehensive approach yields decrease hospital utilization and  low TRM.  Bone Marrow Transplantation. 2010 March;45(3):468-75., which demonstrated that receiving mobilization of stem cells, high dose chemotherapy/total body irradiation and post-transplant follow-up care in the outpatient setting is safe with outstanding survival outcomes and excellent patient satisfaction.

If you receive your transplant in the inpatient or outpatient setting, you will receive the same outstanding care from our dedicated NSH-BMT Interdisciplinary Team. 

Click here to learn more about the NSH-BMT interdisciplinary team.  

Accreditations

NSH-BMT has achieved national Center of Excellence awards from the major insurance managed-care companies. National accreditation includes:

  • Foundation for Accreditation of Cellular Therapy (FACT)*
  • National Marrow Donor Program (NMDP)
  • American Association of Blood Banks (AABB)
  • Food and Drug Administration (FDA)

*The clinical program has received outstanding commendations from each of the assigned FACT Inspectors, resulting in zero deficiencies during the last four re-accreditation cycles, 2003, 2006, 2009, 2012.

Physicians

The NSH–BMT transplant physicians are nationally recognized in the field of blood and marrow  transplantation and leukemia therapy.  The transplant physicians have completed hematopoietic stem cell transplant fellowship training at prestigious universities such as the John Hopkins School of Medicine, University of California at San Diego, the National Institutes of Health (NIH), and the National Heart, Lung and Blood Institute (NHLBI).  The physicians provide leadership to the Program, manage the clinical care of patients in the hospital/outpatient setting, and develop state-of-the-art clinical research protocols and treatment plans. 

How to contact a transplant physicians:

Please call (404) 255-1930 to speak with a physician.

A NSH-BMT physician is on call 24 hours a day, 7 days a week.

To learn more about the physicians at BMTGA, click any of the above physician links or click here.

Interdisciplinary Team

The NSH-BMT team members are highly educated and trained in blood marrow transplantation/leukemia care. These dedicated health professionals provide outstanding patient care where the patient is the center in the treatment pyramid.

Team members include:

  • Physicians
  • Transplant Coordinators
  • Nurse Practitioner/Physician Assistant
  • Nursing Management, Inpatient BMT Leukemia Unit
  • Nurses, Inpatient and Outpatient
  • Health Psychologist
  • Data Coordinators
  • Registered Dietician
  • Critical Care Specialist
  • Marrow/Stem Cell Processing Laboratory
  • Peripheral Blood Stem Cell (PBSC) Nurse Specialist
  • Platelet Apheresis Donor Center Staff
  • Clinical BMT/Leukemia Pharmacists
  • Clinical Research Staff
  • Financial Coordinators
  • Quality Improvement/Assurance Program Staff
  • Registered Dieticians
  • Physical Therapists
  • Chaplain Services
  • Graft-Versus-Host Disease (GVHD) Nurse 

To learn more about the NSH-BMT interdisciplinary team, click here.

Quality Management Program 

Our culture of continuous process improvement, open communication and focusing on improving patient care has resulted in superior survival outcomes and excellent patient satisfaction. Improving the quality of care for our patients is the focus of our Quality Management Program. As part of our Quality Management Plan, all patients are asked to complete a satisfaction survey. The satisfaction survey provides an opportunity for patients and their caregivers to express what was done well and what needs improvement. This comprehensive program enables us to improve treatment protocols, supportive care algorithms, and patient management.

Who is in charge of the NSH-BMT QI Program? 

  • Dr. Kent Holland, our FACT program director, oversees the clinical transplant program's quality management program.
  • NSH-BMT has a designated FACT QI Coordinator.
  • The clinical program has received outstanding commendations from each of the assigned FACT Inspectors, resulting in zero deficiencies during the last 4 re-accreditation cycles, 2003, 2006, 2009, 2012.

Our Quality Management Program consists of the following:

  • A peer reviewed quarterly quality assurance/improvement meeting
  • Corrective Action Plan(s) (Process Improvement) review
  • Bi-annual survival outcome meeting

A patient's physical and emotional well-being are our physicians' primary focus. The NSH-BMT Program offers leading-edge clinical treatment, a commitment to quality, state-of-the-art facilities, and among the best survival rates in the country.

Facilities

The NSH-BMT inpatient unit is a state-of-the-art closed, hepafiltered facility used solely for BMT and leukemia patients. This 36-bed unit has private rooms, a specialized pharmacy with the capabilities to mix complex chemotherapy regimens, a dedicated family room and an exercise room. Nursing and mid-level practitioners undergo extensive annual training and competency.

  • Outpatient Clinic Facility
  • Hematopoietic Marrow/Stem Cell Processing Laboratory
  • Flow Cytometry and Molecular Diagnostic Laboratory
  • The Bone Marrow Transplant Inpatient Unit

View Larger Map

Northside Hospital - Medical Tower
5670 Peachtree Dunwoody Rd.
Suite 1000
Atlanta, GA 30342
Phone: (404) 255-1930

After Hours-Emergency:
Phone: (770) 925-1930
Fax: (404) 255-1939




Copyright © 2014 Northside Hospital|Privacy Policy